Maynard Um
-
-
-
-
-
-
-
MiNK Therapeutics publishes research on iNKT cell therapy platform
-
-
-
-
-
-
-
MiNK Therapeutics, Inc. (INKT) Misses Q4 EPS by 54c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on MiNK Therapeutics (INKT)
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

